Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Personalis, Inc. (PSNL) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Personalis, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1527753.
Total stock buying since 2019: $54,119,782.
Total stock sales since 2019: $57,455,996.
Total stock option exercises since 2019: $627,392.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 6,196 | $33,469 | 0 | $0 |
| 2024 | 3,500,000 | $17,745,000 | 48,039 | $182,865 | 0 | $0 |
| 2023 | 0 | $0 | 67,604 | $109,860 | 0 | $0 |
| 2022 | 314,750 | $3,173,444 | 213,165 | $1,350,870 | 119,491 | $225,863 |
| 2021 | 0 | $0 | 638,187 | $12,952,724 | 57,067 | $341,057 |
| 2020 | 1,774,240 | $31,331,338 | 1,945,798 | $42,826,208 | 250,185 | $55,192 |
| 2019 | 110,000 | $1,870,000 | 0 | $0 | 12,000 | $5,280 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 1,093 | $7,180 | 0 | $0 |
| 2025-05 | 0 | $0 | 3,876 | $19,185 | 0 | $0 |
| 2025-01 | 0 | $0 | 1,227 | $7,104 | 0 | $0 |
| 2024-11 | 0 | $0 | 30,364 | $157,122 | 0 | $0 |
| 2024-08 | 3,500,000 | $17,745,000 | 0 | $0 | 0 | $0 |
| 2024-07 | 0 | $0 | 1,266 | $3,759 | 0 | $0 |
| 2024-06 | 0 | $0 | 6,640 | $8,564 | 0 | $0 |
| 2024-05 | 0 | $0 | 4,004 | $5,524 | 0 | $0 |
| 2024-04 | 0 | $0 | 4,523 | $6,196 | 0 | $0 |
| 2024-01 | 0 | $0 | 1,242 | $1,700 | 0 | $0 |
| 2023-12 | 0 | $0 | 12,931 | $19,007 | 0 | $0 |
| 2023-11 | 0 | $0 | 24,465 | $23,190 | 0 | $0 |
| 2023-07 | 0 | $0 | 1,147 | $2,592 | 0 | $0 |
| 2023-06 | 0 | $0 | 13,230 | $27,385 | 0 | $0 |
| 2023-05 | 0 | $0 | 9,243 | $19,881 | 0 | $0 |
| 2023-03 | 0 | $0 | 5,259 | $14,882 | 0 | $0 |
| 2023-01 | 0 | $0 | 1,329 | $2,923 | 0 | $0 |
| 2022-12 | 0 | $0 | 0 | $0 | 10,000 | $24,400 |
| 2022-11 | 0 | $0 | 4,634 | $12,556 | 0 | $0 |
| 2022-07 | 0 | $0 | 1,264 | $4,942 | 0 | $0 |
| 2022-06 | 0 | $0 | 25,081 | $83,122 | 0 | $0 |
| 2022-05 | 0 | $0 | 11,377 | $59,130 | 0 | $0 |
| 2022-04 | 0 | $0 | 64,430 | $0 | 109,491 | $201,463 |
| 2022-03 | 314,750 | $3,173,444 | 4,982 | $50,715 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-28 | Chen Richard (CHIEF MEDICAL OFFICER AND EVP) | Sale | 452 | 6.57 | 2,969 |
| 2025-07-28 | Tachibana Aaron (CFO AND COO) | Sale | 641 | 6.57 | 4,211 |
| 2025-05-16 | Moore Stephen Michael (SVP and Chief Legal Officer) | Sale | 1,675 | 4.95 | 8,291 |
| 2025-05-16 | Chen Richard (CHIEF MEDICAL OFFICER AND EVP) | Sale | 910 | 4.95 | 4,504 |
| 2025-05-16 | Tachibana Aaron (CFO AND COO) | Sale | 1,291 | 4.95 | 6,390 |
| 2025-01-28 | Chen Richard (CHIEF MEDICAL OFFICER AND EVP) | Sale | 519 | 5.79 | 3,005 |
| 2025-01-28 | Tachibana Aaron (CFO AND COO) | Sale | 708 | 5.79 | 4,099 |
| 2024-11-18 | Moore Stephen Michael (SVP and Chief Legal Officer) | Sale | 1,693 | 3.79 | 6,416 |
| 2024-11-18 | Chen Richard (CHIEF MEDICAL OFFICER AND EVP) | Sale | 921 | 3.79 | 3,490 |
| 2024-11-18 | Tachibana Aaron (CFO AND COO) | Sale | 1,307 | 3.79 | 4,953 |
| 2024-11-01 | Hall Christopher M (PRESIDENT AND CEO) | Sale | 26,443 | 5.38 | 142,263 |
| 2024-08-16 | Tempus Ai, Inc. | Buy | 3,500,000 | 5.07 | 17,745,000 |
| 2024-07-30 | Chen Richard (CHIEF MEDICAL OFFICER AND EVP) | Sale | 524 | 2.97 | 1,556 |
| 2024-07-30 | Tachibana Aaron (CFO AND COO) | Sale | 742 | 2.97 | 2,203 |
| 2024-06-17 | Moore Stephen Michael (SVP and Chief Legal Officer) | Sale | 1,585 | 1.29 | 2,044 |
| 2024-06-17 | Chen Richard (CHIEF MEDICAL OFFICER AND EVP) | Sale | 5,055 | 1.29 | 6,520 |
| 2024-05-17 | Moore Stephen Michael (SVP and Chief Legal Officer) | Sale | 1,731 | 1.38 | 2,388 |
| 2024-05-17 | Chen Richard (CHIEF MEDICAL OFFICER AND EVP) | Sale | 940 | 1.38 | 1,297 |
| 2024-05-17 | Tachibana Aaron (CFO AND COO) | Sale | 1,333 | 1.38 | 1,839 |
| 2024-04-30 | Moore Stephen Michael (SVP and Chief Legal Officer) | Sale | 4,523 | 1.37 | 6,196 |
| 2024-01-29 | Chen Richard (CHIEF MEDICAL OFFICER AND EVP) | Sale | 526 | 1.37 | 720 |
| 2024-01-29 | Tachibana Aaron (CFO AND COO) | Sale | 716 | 1.37 | 980 |
| 2023-12-15 | Moore Stephen Michael (General Counsel) | Sale | 1,476 | 1.47 | 2,169 |
| 2023-12-15 | Chen Richard (Chief Medical Officer and EVP) | Sale | 4,708 | 1.47 | 6,920 |
| 2023-12-15 | Tachibana Aaron (CFO and COO) | Sale | 6,747 | 1.47 | 9,918 |
| 2023-11-16 | Moore Stephen Michael (General Counsel) | Sale | 1,722 | 1.04 | 1,790 |
| 2023-11-16 | Chen Richard (Chief Medical Officer and EVP) | Sale | 940 | 1.04 | 977 |
| 2023-11-16 | Tachibana Aaron (CFO and COO) | Sale | 1,344 | 1.04 | 1,397 |
| 2023-11-01 | Hall Christopher M (President and CEO) | Sale | 20,459 | .93 | 19,026 |
| 2023-07-31 | Chen Richard (Chief Medical Officer and EVP) | Sale | 485 | 2.26 | 1,096 |
| 2023-07-31 | Tachibana Aaron (CFO and COO) | Sale | 662 | 2.26 | 1,496 |
| 2023-06-16 | Moore Stephen Michael (General Counsel) | Sale | 1,509 | 2.07 | 3,123 |
| 2023-06-16 | Chen Richard (Chief Medical Officer and EVP) | Sale | 4,817 | 2.07 | 9,971 |
| 2023-06-16 | Tachibana Aaron (CFO and COO) | Sale | 6,904 | 2.07 | 14,291 |
| 2023-05-17 | Moore Stephen Michael (General Counsel) | Sale | 1,781 | 1.98 | 3,526 |
| 2023-05-17 | Chen Richard (Chief Medical Officer and EVP) | Sale | 971 | 1.98 | 1,922 |
| 2023-05-17 | Tachibana Aaron (CFO and COO) | Sale | 1,389 | 1.98 | 2,750 |
| 2023-05-02 | Moore Stephen Michael (General Counsel) | Sale | 5,102 | 2.29 | 11,683 |
| 2023-03-17 | Chen Richard (Chief Medical Officer and EVP) | Sale | 1,314 | 2.83 | 3,718 |
| 2023-03-17 | Tachibana Aaron (CFO and COO) | Sale | 3,945 | 2.83 | 11,164 |
| 2023-01-31 | Chen Richard (Chief Medical Officer) | Sale | 562 | 2.20 | 1,236 |
| 2023-01-31 | Tachibana Aaron (Chief Financial Officer) | Sale | 767 | 2.20 | 1,687 |
| 2022-12-14 | West John Stephen (President and CEO) | Option Ex | 10,000 | 2.44 | 24,400 |
| 2022-11-16 | Moore Stephen Michael (General Counsel) | Sale | 2,045 | 2.71 | 5,541 |
| 2022-11-16 | Chen Richard (Chief Medical Officer) | Sale | 1,295 | 2.71 | 3,509 |
| 2022-11-16 | Tachibana Aaron (Chief Financial Officer) | Sale | 1,294 | 2.71 | 3,506 |
| 2022-07-28 | Chen Richard (Chief Medical Officer) | Sale | 632 | 3.91 | 2,471 |
| 2022-07-28 | Tachibana Aaron (Chief Financial Officer) | Sale | 632 | 3.91 | 2,471 |
| 2022-06-17 | Chen Richard (Chief Medical Officer) | Sale | 1,565 | 3.29 | 5,148 |
| 2022-06-17 | Tachibana Aaron (Chief Financial Officer) | Sale | 3,440 | 3.29 | 11,317 |
| 2022-06-15 | Moore Stephen Michael (General Counsel) | Sale | 1,832 | 3.24 | 5,935 |
| 2022-06-15 | Chen Richard (Chief Medical Officer) | Sale | 6,818 | 3.24 | 22,090 |
| 2022-06-15 | Tachibana Aaron (Chief Financial Officer) | Sale | 6,818 | 3.24 | 22,090 |
| 2022-06-02 | Chen Richard (Chief Medical Officer) | Sale | 421 | 3.59 | 1,511 |
| 2022-06-02 | Tachibana Aaron (Chief Financial Officer) | Sale | 4,187 | 3.59 | 15,031 |
| 2022-05-16 | Moore Stephen Michael (General Counsel) | Sale | 664 | 4.86 | 3,227 |
| 2022-05-16 | West John Stephen (President and CEO) | Sale | 2,408 | 4.86 | 11,702 |
| 2022-05-16 | Chen Richard (Chief Medical Officer) | Sale | 1,286 | 4.86 | 6,249 |
| 2022-05-16 | Tachibana Aaron (Chief Financial Officer) | Sale | 1,286 | 4.86 | 6,249 |
| 2022-05-02 | Moore Stephen Michael (General Counsel) | Sale | 5,733 | 5.53 | 31,703 |
| 2022-04-20 | West John Stephen (President and CEO) | Option Ex | 45,061 | 1.84 | 82,912 |
| 2022-04-13 | West John Stephen (President and CEO) | Sale | 64,430 | .00 | 0 |
| 2022-04-13 | West John Stephen (President and CEO) | Option Ex | 64,430 | 1.84 | 118,551 |
| 2022-03-03 | Nieh Peter (Other) | Buy | 265,761 | 10.11 | 2,685,514 |
| 2022-03-02 | Chen Richard (Chief Medical Officer) | Sale | 471 | 10.18 | 4,794 |
| 2022-03-02 | Tachibana Aaron (Chief Financial Officer) | Sale | 4,511 | 10.18 | 45,921 |
| 2022-03-02 | Nieh Peter (Other) | Buy | 48,989 | 9.96 | 487,930 |
| 2022-01-28 | Chen Richard (Chief Medical Officer) | Sale | 705 | 9.93 | 7,000 |
| 2022-01-28 | Tachibana Aaron (Chief Financial Officer) | Sale | 705 | 9.93 | 7,000 |
| 2022-01-19 | West John Stephen (President and CEO) | Sale | 64,503 | 11.01 | 710,178 |
| 2022-01-18 | West John Stephen (President and CEO) | Sale | 35,484 | 11.73 | 416,227 |
| 2021-12-17 | West John Stephen (President and CEO) | Sale | 2,732 | 12.80 | 34,969 |
| 2021-12-17 | Chen Richard (Chief Medical Officer) | Sale | 1,563 | 12.80 | 20,006 |
| 2021-12-17 | Tachibana Aaron (Chief Financial Officer) | Sale | 3,437 | 12.80 | 43,993 |
| 2021-12-16 | West John Stephen (President and CEO) | Sale | 97,268 | 13.42 | 1,305,336 |
| 2021-12-02 | Chen Richard (Chief Medical Officer) | Sale | 419 | 12.92 | 5,413 |
| 2021-12-02 | Tachibana Aaron (Chief Financial Officer) | Sale | 4,184 | 12.92 | 54,057 |
| 2021-11-30 | West John Stephen (President and CEO) | Sale | 100,000 | 13.65 | 1,365,000 |
| 2021-11-17 | West John Stephen (President and CEO) | Sale | 2,348 | 17.04 | 40,009 |
| 2021-11-17 | Chen Richard (Chief Medical Officer) | Sale | 1,253 | 17.04 | 21,351 |
| 2021-11-17 | Tachibana Aaron (Chief Financial Officer) | Sale | 1,253 | 17.04 | 21,351 |
| 2021-10-12 | West John Stephen (President and CEO) | Sale | 100,000 | 19.33 | 1,932,999 |
| 2021-09-17 | Chen Richard (Chief Scientific Officer) | Sale | 1,088 | 21.25 | 23,120 |
| 2021-09-17 | Tachibana Aaron (Chief Financial Officer) | Sale | 3,152 | 21.25 | 66,980 |
| 2021-09-02 | Chen Richard (Chief Scientific Officer) | Sale | 291 | 21.92 | 6,378 |
| 2021-09-02 | Tachibana Aaron (Chief Financial Officer) | Sale | 3,820 | 21.92 | 83,734 |
| 2021-08-06 | Chen Richard (Chief Scientific Officer) | Sale | 4,436 | 21.22 | 94,131 |
| 2021-08-06 | Chen Richard (Chief Scientific Officer) | Option Ex | 31,128 | 10.59 | 329,645 |
| 2021-07-08 | West John Stephen (President and CEO) | Sale | 110,000 | 22.54 | 2,479,400 |
| 2021-06-17 | Chen Richard (Chief Scientific Officer) | Sale | 1,101 | 22.75 | 25,047 |
| 2021-06-08 | West John Stephen (President and CEO) | Sale | 110,000 | 22.66 | 2,492,050 |
| 2021-06-02 | Tachibana Aaron (Chief Financial Officer) | Sale | 2,899 | 21.57 | 62,531 |
| 2021-04-01 | Chen Richard (Chief Scientific Officer) | Sale | 40,000 | 25.75 | 1,030,120 |
| 2021-04-01 | Chen Richard (Chief Scientific Officer) | Option Ex | 12,517 | .44 | 5,507 |
| 2021-03-17 | Chen Richard (Chief Scientific Officer) | Sale | 1,130 | 26.73 | 30,204 |
| 2021-03-17 | Tachibana Aaron (Chief Financial Officer) | Sale | 2,446 | 26.73 | 65,381 |
| 2021-03-02 | Chen Richard (Chief Scientific Officer) | Sale | 345 | 32.60 | 11,247 |
| 2021-03-02 | Tachibana Aaron (Chief Financial Officer) | Sale | 3,022 | 32.60 | 98,517 |
| 2021-02-01 | Chen Richard (Chief Scientific Officer) | Sale | 40,000 | 38.48 | 1,539,400 |
| 2021-02-01 | Chen Richard (Chief Scientific Officer) | Option Ex | 13,422 | .44 | 5,905 |
| 2020-12-17 | Chen Richard (Chief Scientific Officer) | Sale | 1,087 | 36.37 | 39,534 |
| 2020-12-17 | Tachibana Aaron (Chief Financial Officer) | Sale | 2,391 | 36.37 | 86,960 |
| 2020-12-02 | Chen Richard (Chief Scientific Officer) | Sale | 293 | 27.76 | 8,133 |
| 2020-12-02 | Tachibana Aaron (Chief Financial Officer) | Sale | 2,926 | 27.76 | 81,225 |
| 2020-12-01 | Chen Richard (Chief Scientific Officer) | Sale | 40,000 | 27.95 | 1,117,800 |
| 2020-12-01 | Chen Richard (Chief Scientific Officer) | Option Ex | 40,000 | .44 | 17,600 |
| 2020-10-20 | Abingworth Llp | Sale | 130,486 | 27.66 | 3,609,242 |
| 2020-10-19 | Abingworth Llp | Sale | 196,423 | 27.86 | 5,472,344 |
| 2020-10-16 | Abingworth Llp | Sale | 94,218 | 26.68 | 2,513,736 |
| 2020-10-15 | Abingworth Llp | Sale | 3,700 | 26.32 | 97,384 |
| 2020-10-14 | Abingworth Llp | Sale | 81,925 | 27.08 | 2,218,529 |
| 2020-10-13 | Abingworth Llp | Sale | 86,819 | 28.43 | 2,468,264 |
| 2020-10-12 | Abingworth Llp | Sale | 115,541 | 29.09 | 3,361,087 |
| 2020-10-01 | Chen Richard (Chief Scientific Officer) | Sale | 40,000 | 21.96 | 878,600 |
| 2020-10-01 | Chen Richard (Chief Scientific Officer) | Option Ex | 37,452 | .44 | 16,478 |
| 2020-09-17 | Chen Richard (Chief Scientific Officer) | Sale | 1,120 | 22.74 | 25,468 |
| 2020-09-17 | Tachibana Aaron (Chief Financial Officer) | Sale | 2,463 | 22.74 | 56,008 |
| 2020-09-02 | Chen Richard (Chief Scientific Officer) | Sale | 291 | 22.99 | 6,690 |
| 2020-09-02 | Tachibana Aaron (Chief Financial Officer) | Sale | 2,899 | 22.99 | 66,648 |
| 2020-08-18 | Abingworth Llp | Sale | 986,842 | 19.00 | 18,749,998 |
| 2020-08-14 | Janmohamed Arif (Other) | Buy | 1,315,789 | 19.00 | 24,999,991 |
| 2020-08-14 | Chen Richard (Chief Scientific Officer) | Sale | 32,000 | 20.13 | 644,256 |
| 2020-08-14 | Chen Richard (Chief Scientific Officer) | Option Ex | 28,566 | .00 | 0 |
| 2020-08-14 | Ludlum Ken (Director) | Sale | 20,000 | 20.23 | 404,700 |
| 2020-06-22 | Chen Richard (Chief Scientific Officer) | Sale | 1,085 | 12.37 | 13,421 |
| 2020-06-02 | Janmohamed Arif (Other) | Buy | 380,654 | 13.98 | 5,321,542 |
| 2020-06-01 | Janmohamed Arif (Other) | Buy | 77,797 | 12.98 | 1,009,805 |
| 2020-06-01 | Chen Richard (Chief Scientific Officer) | Sale | 289 | 13.19 | 3,811 |
| 2020-03-27 | Chen Richard (Chief Scientific Officer) | Option Ex | 15,000 | .00 | 0 |
| 2020-03-25 | Chen Richard (Chief Scientific Officer) | Option Ex | 10,000 | .00 | 0 |
| 2020-03-09 | Chen Richard (Chief Scientific Officer) | Sale | 1,000 | 7.84 | 7,840 |
| 2020-03-09 | Chen Richard (Chief Scientific Officer) | Option Ex | 1,000 | .00 | 0 |
| 2020-03-02 | Chen Richard (Chief Scientific Officer) | Sale | 1,000 | 8.76 | 8,760 |
| 2020-03-02 | Chen Richard (Chief Scientific Officer) | Option Ex | 1,000 | .00 | 0 |
| 2020-02-25 | Chen Richard (Chief Scientific Officer) | Sale | 101,000 | 8.77 | 885,770 |
| 2020-02-25 | Chen Richard (Chief Scientific Officer) | Option Ex | 101,000 | .00 | 0 |
| 2020-02-07 | Ludlum Ken (Director) | Option Ex | 4,167 | 3.80 | 15,834 |
| 2020-01-07 | Chen Richard (Chief Scientific Officer) | Option Ex | 12,000 | .44 | 5,280 |
| 2019-12-20 | Chen Richard (Chief Scientific Officer) | Option Ex | 12,000 | .44 | 5,280 |
| 2019-06-24 | Ludlum Ken (Director) | Buy | 70,000 | 17.00 | 1,190,000 |
| 2019-06-24 | Ricci Paul (Director) | Buy | 40,000 | 17.00 | 680,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of PSNL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Personalis, Inc. (symbol PSNL, CIK number 1527753) see the Securities and Exchange Commission (SEC) website.